Correlation Between Humasis and Bridge Biotherapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Humasis and Bridge Biotherapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Humasis and Bridge Biotherapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Humasis Co and Bridge Biotherapeutics, you can compare the effects of market volatilities on Humasis and Bridge Biotherapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Humasis with a short position of Bridge Biotherapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Humasis and Bridge Biotherapeutics.

Diversification Opportunities for Humasis and Bridge Biotherapeutics

-0.56
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Humasis and Bridge is -0.56. Overlapping area represents the amount of risk that can be diversified away by holding Humasis Co and Bridge Biotherapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Bridge Biotherapeutics and Humasis is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Humasis Co are associated (or correlated) with Bridge Biotherapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Bridge Biotherapeutics has no effect on the direction of Humasis i.e., Humasis and Bridge Biotherapeutics go up and down completely randomly.

Pair Corralation between Humasis and Bridge Biotherapeutics

Assuming the 90 days trading horizon Humasis Co is expected to generate 0.91 times more return on investment than Bridge Biotherapeutics. However, Humasis Co is 1.1 times less risky than Bridge Biotherapeutics. It trades about -0.02 of its potential returns per unit of risk. Bridge Biotherapeutics is currently generating about -0.13 per unit of risk. If you would invest  208,000  in Humasis Co on September 5, 2024 and sell it today you would lose (12,800) from holding Humasis Co or give up 6.15% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Humasis Co  vs.  Bridge Biotherapeutics

 Performance 
       Timeline  
Humasis 

Risk-Adjusted Performance

5 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Humasis Co are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Humasis sustained solid returns over the last few months and may actually be approaching a breakup point.
Bridge Biotherapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Bridge Biotherapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, Bridge Biotherapeutics is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Humasis and Bridge Biotherapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Humasis and Bridge Biotherapeutics

The main advantage of trading using opposite Humasis and Bridge Biotherapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Humasis position performs unexpectedly, Bridge Biotherapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bridge Biotherapeutics will offset losses from the drop in Bridge Biotherapeutics' long position.
The idea behind Humasis Co and Bridge Biotherapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.

Other Complementary Tools

Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Global Correlations
Find global opportunities by holding instruments from different markets
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance